In a randomized, placebo-controlled Phase 2a trial, PP405 met its primary safety endpoint and secondary pharmacokinetic endpoint, showed no systemic absorption, and was well tolerated across a diverse patient population
Si es tu caso, consulta con tu mdico
If you suspect you've experienced a side effect from Ozempic, you can report this through the MHRA Yellow Card scheme, which helps monitor the safety of medicines in the UK
Body measurements, energy levels, sleep quality, and mood provide a more complete picture of how your protocol is progressing
The best model predicted, with more than 90% accuracy, which prescribers favored compounded GLP-1s